Physician

David Ronald Squires, M.D.

According to 2025 Medicare claims, David Squires, M.D. (NPI: 1376520148) practices medical oncology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Columbia, GA. This provider's primary affiliated billing organization is AUGUSTA ONCOLOGY ASSOCIATES PC (NPI: 1912917824; TIN: 581481590) and primary practice location at 30909-6520.

Squires' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 920 traditional Medicare patients, billed 269,688 HCPCS/CPT codes, and received $4,652,734 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,262 prescription claims across 350 beneficiaries totaling $6,196,722 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 74 claims. Open Payments data shows 151 records totaling $10,449. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,049,265 to $4,652,734. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,784,927 to $6,196,722. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,811 and ending at $2,795.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	726	213,449	$2,049,265
2016	706	280,799	$2,485,514
2017	752	314,812	$2,923,510
2018	849	245,777	$3,256,348
2019	883	362,645	$4,623,601
2020	913	334,161	$4,673,749
2021	850	277,102	$3,470,232
2022	810	239,017	$3,266,820
2023	882	275,063	$4,063,666
2024	920	269,688	$4,652,734

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	234	1,684	$1,784,927
2016	256	1,787	$2,763,576
2017	288	1,956	$3,081,719
2018	312	1,902	$3,911,971
2019	352	2,364	$4,330,965
2020	327	2,471	$5,479,725
2021	302	2,291	$5,840,100
2022	282	1,811	$5,078,299
2023	314	1,806	$5,046,874
2024	350	2,262	$6,196,722

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	66	$62,347
2016	N/R	91	$43,781
2017	N/R	N/R	N/R
2018	N/R	12	$2,570
2019	N/R	27	$4,323
2020	N/R	50	$6,123
2021	N/R	47	$5,592
2022	N/R	86	$3,859
2023	N/R	42	$1,845
2024	N/R	74	$3,565

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	327	532	$88
80053	Blood test, comprehensive group of blood chemicals	632	1,603	$10
36415	Insertion of needle into vein for collection of blood sample	682	1,861	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	661	1,812	$8
83540	Iron level	223	361	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	54	1,512	$783,724
Xtandi	Enzalutamide	47	1,590	$724,964
Imbruvica	Ibrutinib	39	1,092	$624,661
Revlimid	Lenalidomide	28	784	$541,934
Brukinsa	Zanubrutinib	35	1,050	$507,287

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	31	$2,114
J8521	Capecitabine, oral, 500 mg	N	N/R	15	$973
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$282
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	13	$196

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	151	$10,449	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Ronald Squires, M.D.?

Tedicare shows public-source Medicare data for David Ronald Squires, M.D. (NPI 1376520148), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Ronald Squires, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Ronald Squires, M.D.?

David Ronald Squires, M.D. is linked to AUGUSTA ONCOLOGY ASSOCIATES PC (billing NPI 1912917824) in the available physician profile data.

Does David Ronald Squires, M.D. have Open Payments data?

David Ronald Squires, M.D. has 151 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.